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iomineralization is a highly regulated process that
 
plays a major role during the development of skeletal
tissues. Despite its obvious importance, little is known
about its regulation. Previously, it has been demonstrated
that retinoic acid (RA) stimulates terminal differentiation
and mineralization of growth plate chondrocytes (Iwamoto,
M., I.M. Shapiro, K. Yagumi, A.L. Boskey, P.S. Leboy, S.L.
Adams, and M. Paciﬁci. 1993. 
 
Exp. Cell Res
 
. 207:413–420).
In this study, we provide evidence that RA treatment of growth
plate chondrocytes caused a series of events eventually
leading to mineralization of these cultures: increase in
cytosolic calcium concentration, followed by up-regulation
of annexin II, V, and VI gene expression, and release of
annexin II–, V–, VI– and alkaline phosphatase–containing
matrix vesicles. Cotreatment of growth plate chondrocytes
with RA and BAPTA-AM, a cell permeable Ca
 
2
 
 
 
 chelator,
inhibited the up-regulation of annexin gene expression
and mineralization of these cultures. Interestingly, only
matrix vesicles isolated from RA-treated cells that contained
B
 
annexins,  were able to take up Ca
 
2
 
 
 
 and mineralize,
whereas vesicles isolated from untreated or RA/BAPTA-
treated cells, that contained no or only little annexins were
not able to take up Ca
 
2
 
 
 
 and mineralize. Cotreatment of
 
chondrocytes with RA and EDTA revealed that increases in the
cytosolic calcium concentration were due to inﬂux of extra-
cellular calcium. Interestingly, the novel 1,4-benzothiazepine
derivative K-201, a speciﬁc annexin Ca
 
2
 
 
 
 channel blocker,
or antibodies speciﬁc for annexin II, V, or VI inhibited the
increases in cytosolic calcium concentration in RA-treated
chondrocytes. These ﬁndings indicate that annexins II, V,
 
and VI form Ca
 
2
 
 
 
 channels in the plasma membrane of
terminally differentiated growth plate chondrocytes and
 
mediate Ca
 
2
 
 
 
 inﬂux into these cells. The resulting increased
cytosolic calcium concentration leads to a further up-
regulation of annexin II, V, and VI gene expression, the
release of annexin II–, V–, VI– and alkaline phosphatase–
containing matrix vesicles, and the initiation of mineralization
by these vesicles.
 
Introduction
 
Mineralization plays a crucial role during normal develop-
ment and replacement of cartilaginous skeleton via endoch-
ondral ossification. Mineralization of growth plate cartilage
is restricted to terminally differentiated chondrocytes, and
thus the mineralization process must be under cellular con-
trol (Kirsch and von der Mark, 1992; Kirsch et al., 1997b).
In general, mineralization is restricted to skeletal tissues and
teeth, where it is required for the proper function of these
tissues. However, uncontrolled (pathological) mineralization
can occur in all soft tissues. For example, excessive mineral
deposition accompanies osteoarthritis. Crystal formation
in articular cartilage may play a major role in the onset
of inflammation and cartilage destruction (Doyle, 1982;
Mitchell et al., 1992; Kirsch et al., 2000c). Calcification of
cardiovascular tissues including arteries, heart valves, and
cardiac muscle contributes to morbidity and mortality
(Giachelli, 1999).
Annexins II, V, and VI are highly expressed in hypertrophic
and mineralizing growth plate cartilage and in bone. These
molecules belong to the annexin protein family, which have
in common that they bind to acidic phospholipids in the
presence of calcium (Crompton et al., 1988; Genge et al.,
1989; Kirsch et al., 2000c, 2001). Annexin II and V each
contain four 70–80 amino acid repeats with an annexin
consensus sequence, whereas annexin VI contains eight such
repeats. These four or eight repeats form the conserved core
region, which is responsible for the Ca
 
2
 
 
 
-dependent binding
of the proteins to phospholipids. In contrast, the NH
 
2
 
-
terminal regions of the annexins are highly variable and may
contribute to the specific functions of the various annexins
 
Address correspondence to Thorsten Kirsch, Dept. of Orthopaedics and
Rehabilitation, H089, Penn State College of Medicine, Hershey Medical
Center, 500 University Dr., Hershey, PA 17033. Tel.: (717) 531-7788.
Fax: (717) 531-1607. E-mail: tkirsch@psu.edu
 
Key words: annexin; calcium; matrix vesicles; mineralization; retinoic acid 
1062 The Journal of Cell Biology 
 
|
 
 
 
Volume 157, Number 6, 2002
 
(Geisow et al., 1988). Previous studies have shown that an-
nexins II, V, and VI form Ca
 
2
 
 
 
 channels when inserted
into artificial phospholipid bilayers or mediate Ca
 
2
 
 
 
 influx
into liposomes (Berendes et al., 1993; Chen et al., 1993;
Benz et al., 1996; Burger et al., 1996; Matsuda et al.,
1997; Kirsch et al., 2000b). Recently, we have demon-
strated that annexins II, V, and VI form Ca
 
2
 
 
 
 channels in
matrix vesicles (Kirsch et al., 2000b). Matrix vesicles are
particles that are released from the plasma membrane of
mineralizing cells. These vesicles have the critical role of
initiating the mineralization process (Anderson, 1995;
Kirsch et al., 1997b). The first mineral phase forms inside
the vesicles in a protected environment. Once these in-
tralumenal crystals have reached a certain size they rupture
the vesicle membrane and grow out into the extracellular
matrix (Anderson, 1995). For the formation of the first
intralumenal crystals, phase channel or transporter sys-
tems are required to mediate influx of mineral ions into
the vesicles. Annexins II, V, and VI enable the influx of
Ca
 
2
 
 
 
 into matrix vesicles and the formation of the first in-
tralumenal mineral phase. The inhibition of annexin Ca
 
2
 
 
 
channel activities led to a loss of the ability of these vesi-
cles to mineralize (Kirsch et al., 2000b). Other studies
have shown that matrix vesicles contain a Na
 
 
 
-coupled P
 
i
 
symport system that mediates the influx of inorganic
phosphate into the vesicles (Montessuit et al., 1991,
1995). The total amounts of Ca
 
2
 
 
 
 and P
 
i
 
 in matrix vesicles
are significantly higher than those in adjacent cells or in
the extracellular fluid. The vast majority of Ca
 
2
 
 
 
 and
about half of P
 
i
 
 are in insoluble, protein/lipid-bound form
in the vesicles, which allows permanent annexin-mediated
Ca
 
2
 
 
 
 influx into the vesicles.
Ultrastructural studies have shown a high concentration
of matrix vesicles in the reserve zone of growth plate carti-
lage and another peak concentration in the hypertrophic
zone just before the onset of matrix mineralization (Reinholt
et al., 1982; Buckwalter et al., 1987). Furthermore, we have
described a qualitative difference between vesicles released
by the various growth plate chondrocytes, and that only
mineralization-competent growth plate chondrocytes release
specialized matrix vesicles that are capable of initiating the
mineralization process, whereas nonmineralizing growth
plate chondrocytes release vesicles that do not mineralize
(Kirsch et al., 1997b, 2000a). Thus, it is reasonable to hy-
pothesize that chondrocytes regulate the mineralization pro-
cess by controlling the release of specialized matrix vesicles
and that only mineralization-competent chondrocytes re-
lease matrix vesicles that initiate the mineralization process.
However, very little is known about the mechanisms in-
volved in regulating the release of these mineralization-com-
petent matrix vesicles from the plasma membrane of growth
plate chondrocytes.
Calcium is recognized as an important regulatory element
for many cellular processes. Increase in the cytosolic calcium
concentration, [Ca
 
2
 
 
 
]
 
i
 
, which occurs in many cell types after
stimulation by hormones, controls a diverse range of cell func-
tions including adhesion, motility, gene expression, and prolif-
eration. Several studies have provided evidences that growth
plate chondrocytes accumulate large amounts of cytosolic cal-
cium just before the initiation of mineralization (Gunter et al.,
1990; Kirsch et al., 1992; Iannotti et al., 1994). Nevertheless,
little is known about the mechanisms involved in alterations of
Ca
 
2
 
 
 
 homeostasis in growth plate chondrocytes and the role of
altered Ca
 
2
 
 
 
 homeostasis in chondrocyte differentiation and
mineralization. Interestingly, vesiculation or ectocytosis of the
plasma membrane has been shown to be dependent on an in-
flux of calcium in the cytoplasm of many cell types. For ex-
ample, Ca
 
2
 
 
 
 ionophores can cause microvesiculation and
membrane shedding in a variety of cell types including chon-
drocytes, fibroblasts, neutrophils, and platelets (Wiedmer et
al., 1990; Iannotti et al., 1994; Bucki et al., 1998). Thus, it is
possible that annexins II, V, and VI form Ca
 
2
 
 
 
 channels in hy-
pertrophic growth plate chondrocytes leading to influx of
Ca
 
2
 
 
 
 and alterations of Ca
 
2
 
 
 
 homeostasis. The altered Ca
 
2
 
 
 
homeostasis leads to the release of annexin-containing, miner-
alization-competent matrix vesicles.
Previously we and others have shown that retinoic acid
(RA)* affects the release of annexin-containing matrix vesi-
cles and stimulates mineralization of hypertrophic growth
plate chondrocytes (Iwamoto et al., 1993; Kirsch et al.,
2000a). To test our hypothesis that annexin-mediated alter-
ations in Ca
 
2
 
 
 
 homeostasis of growth plate chondrocytes
might regulate the mineralization process of growth plate
chondrocytes, we cultured hypertrophic growth plate chon-
drocytes in the presence of RA and 1,2-bis(2-aminophe-
noxy)ethane-N,N,N
 
 
 
,N
 
 
 
-tetraacetic acid tetrakis(acetoxym-
ethyl ester) (BAPTA-AM), a cell permeable Ca
 
2
 
 
 
 chelator,
K-201, a specific annexin Ca
 
2
 
 
 
 channel blocker (Kaneko,
1994; Kaneko et al., 1997; Kirsch et al., 2000b), or antibod-
ies specific for annexin II, V, or VI. We measured changes in
[Ca
 
2
 
 
 
]
 
i
 
, and characterized matrix vesicles isolated from these
cultures and the degree of mineralization in these cultures.
 
*Abbreviations used in this paper: APase, alkaline phosphatase; BAPTA-
AM, 1,2-bis(2-aminophenoxy)ethane-N,N,N
 
 
 
,N
 
 
 
-tetraacetic acid tet-
rakis(acetoxymethyl ester); RA, retinoic acid.
Figure 1. Cytosolic calcium concentration of untreated, RA- and 
RA/EDTA-treated growth plate chondrocytes. After growth plate 
chondrocytes isolated from 19-d chick embryonic tibia reached 
confluency, the cells were cultured in the absence or presence 
of 35 nM RA, or RA and 5 mM EDTA for 1 d. The cytosolic calcium 
concentration, [Ca
2 ]i, of chondrocytes was measured using fura-2AM 
as described in Materials and methods. Data were obtained from 
four different experiments and values are mean   SD. ( , P   0.01 
vs. untreated cultures.) 
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Results
 
Alteration in Ca
 
2
 
 
 
 homeostasis and mineralization of 
growth plate chondrocytes
 
We and others have shown that RA treatment stimulates
mineralization of hypertrophic growth plate chondrocytes
(Iwamoto et al., 1993; Kirsch et al., 2000a). In addition, hy-
pertrophic differentiation of chondrocytes is accompanied
by an increase in [Ca
 
2
 
 
 
]
 
i
 
 (Iannotti and Brighton, 1989;
Gunter et al., 1990; Kirsch et al., 1992). Since alterations in
Ca
 
2
 
 
 
 homeostasis affect differentiation processes in many
cell types, we first determined whether RA treatment alters
Ca
 
2
 
 
 
 homeostasis of growth plate chondrocytes. As shown
in Fig. 1, 1-d treatment of chondrocytes isolated from the
hypertrophic zone of 19-d embryonic chick tibia growth
plate cartilage with RA led to an approximately threefold in-
crease in [Ca
 
2
 
 
 
]
 
i
 
 ([Ca
 
2
 
 
 
]
 
i
 
 of untreated chondrocytes, 887
nM; [Ca
 
2
 
 
 
]
 
i
 
 of RA-treated chondrocytes, 2,867 nM). Co-
treatment of growth plate chondrocytes with RA and EDTA
abolished the increase in [Ca
 
2
 
 
 
]
 
i
 
, indicating that the increase
in [Ca
 
2
 
 
 
]
 
i
 
 was due to the influx of extracellular Ca
 
2
 
 
 
 into the
cells.
To determine whether the increase in [Ca
 
2
 
 
 
]
 
i
 
 affects miner-
alization of growth plate chondrocytes, we treated cells with
RA and BAPTA-AM. After 6-d treatment with RA, cultures
were heavily calcified as indicated by the intense alizarin red S
staining (Fig. 2). In contrast untreated or RA/BAPTA-treated
cultures showed significantly less alizarin red S staining (Fig.
2). Alkaline phosphatase (APase) activity, an enzyme whose
activity is up-regulated just before the onset of mineralization
(Bonucci et al., 1992), was also significantly increased in RA-
treated cells compared with the APase activities in untreated
or RA/BAPTA-treated cells (Fig. 3).
Previous studies have shown that matrix vesicles, which are
released from the plasma membrane of mineralizing chondro-
cytes, initiate the mineralization process (Anderson, 1995;
Figure 2. Extent of matrix mineralization in chondrocyte cultures 
treated with RA or RA/BAPTA. Growth plate chondrocytes were 
treated with RA or RA and BAPTA for 6 d. (A) Note the intense 
alizarin red S staining in cultures treated with RA. In contrast, less 
staining was detected in untreated or RA/BAPTA-treated cultures. 
(B) To quantitate the alizarin red S stain, each dish was incubated 
with 100 mM cetylpyridium chloride for 1 h. The alizarin red stain 
released into solution was collected, diluted when necessary, and 
read as units of alizarin red released (1 unit is equivalent to 1 unit 
optical density at 570 nm) per mg of protein. Data were obtained 
from four different experiments and values are mean   SD. 
( , P   0.01 vs. untreated cultures.)
Figure 3. Alkaline phosphatase (APase) activity in untreated, RA-, 
and RA/BAPTA-treated chondrocyte cultures. After 6-d treatment, 
APase activity in the cell layer of RA-treated was significantly higher 
than APase activities in untreated or RA/BAPTA-treated cultures. 
Data were obtained from four different experiments; values are 
mean   SD. ( , P   0.01 vs. untreated cultures.)
Figure 4. Alkaline phosphatase (APase) activity in matrix vesicles 
isolated from untreated, RA- and RA/BAPTA-treated growth plate 
chondrocytes. After 3 d, matrix vesicles were isolated from the cell 
layer of untreated, RA-, and RA/BAPTA-treated chondrocytes as 
described in Materials and methods. APase activity was  10-fold 
increased in matrix vesicles isolated from RA-treated cultures 
compared with the activity in vesicles isolated from untreated or 
RA/BAPTA-treated cultures. Data were obtained from four different 
experiments; values are mean   SD. ( , P   0.01 vs. APase activity 
of vesicles isolated from untreated cultures.) 
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Kirsch et al., 1997b). In addition, we have demonstrated that
only matrix vesicles that contain annexins II, V, and VI, and
APase were able to initiate mineralization (Kirsch et al.,
1997b). To test if alterations of Ca
 
2
 
 
 
 homeostasis affect ma-
trix vesicle release and/or composition, we isolated matrix vesi-
cles from untreated, RA-treated, and RA/BAPTA-treated cul-
tures and compared their composition and functions. APase
activity (Fig. 4) and the amount of annexins II, V, and VI
(Fig. 5) were significantly increased in matrix vesicles isolated
from RA-treated cultures compared with vesicles isolated from
untreated cultures. Matrix vesicles isolated from RA-treated
chondrocytes were able to take up significant amounts of Ca
 
2
 
 
 
when incubated in synthetic cartilage lymph for 24 h. In con-
trast, vesicles isolated from untreated cultures were not able to
take up significant amounts of Ca
 
2
 
 
 
 (Fig. 6), confirming our
previous findings that only vesicles containing Ca
 
2
 
 
 
 channels
formed by annexin II, V, and VI are able to take up Ca
 
2
 
 
 
(Kirsch et al., 1997b, 2000b). Interestingly, matrix vesicles
isolated from RA/BAPTA-treated cultures showed similar pro-
perties as vesicles isolated from untreated cultures. These vesi-
cles contained little APase activity, annexins II, V, and VI, and
showed no significant Ca
 
2
 
 
 
 uptake (Figs. 4–6). These findings
indicate that alterations of Ca
 
2
 
 
 
 homeostasis in growth plate
chondrocytes regulate the release of mineralization-competent
matrix vesicles and subsequent mineralization.
Figure 5. Amount of annexins II, V, and VI in matrix vesicles 
isolated from untreated, RA- or RA/BAPTA-treated chondrocytes. 
Matrix vesicle fractions (50  g of total protein) isolated from 3-d 
untreated, RA-, or RA/BAPTA-treated cultures were subjected to 
SDS-PAGE and immunoblotting using antibodies specific for 
annexin II, V, or VI (A). The optical densities of the annexin bands 
were quantitated by densitometry. The optical densities obtained for 
annexin bands in matrix vesicle fractions isolated from untreated 
cultures were set as 1. Data were obtained from four different 
experiments; values are mean   SD. ( , P   0.01 vs. vesicles isolated 
from untreated cultures.)
Figure 6. Ca
2  uptake by matrix vesicles isolated from untreated, 
RA-, and RA/BAPTA-treated chondrocytes. Matrix vesicles were 
isolated from 3-d untreated, RA- or RA/BAPTA-treated chondrocytes. 
The vesicle fractions (100  g of total protein) were incubated in 
synthetic cartilage lymph for 24 h at 37 C and Ca
2  uptake of these 
vesicle fractions was measured as described in Materials and methods. 
Note that only vesicles isolated from RA-treated cultures showed 
significant Ca
2  uptake, whereas vesicles isolated from untreated or 
RA/BAPTA-treated cultures showed no significant Ca
2  uptake. Ca
2  
uptake by matrix vesicles isolated from RA-treated cultures was set 
as 1. Data were obtained from four different experiments; values are 
mean   SD.
Figure 7. Amount of annexin II, V, or VI bound to the plasma 
membrane of untreated, RA-, and RA/BAPTA-treated growth plate 
chondrocytes. The membrane and cytosolic fractions were isolated 
from 3-d untreated, RA-, or RA/BAPTA-treated chondrocytes and 
analyzed by SDS-PAGE and immunoblotting using antibodies specific 
for annexin II, V, or VI. The optical densities of the annexin bands in 
membrane and cytosolic fractions were quantitated by densitometry. 
Data were obtained from four different experiments; values are
mean   SD. ( , P   0.01 vs. untreated cultures.) Retinoic acid, annexins, and chondrocyte differentiation | Wang and Kirsch 1065
Annexins mediate Ca
2  influx into growth 
plate chondrocytes
Based on our previous findings showing that annexins II, V,
and VI form Ca
2  channels in matrix vesicles enabling Ca
2 
influx into these particles (Kirsch et al., 2000b), we hypoth-
esized that these annexins might also form Ca
2  channels
in the plasma membrane of growth plate chondrocytes,
thereby regulating Ca
2  homeostasis and ultimately miner-
alization. First, we tested whether the amount of mem-
brane-bound annexins increased in RA-treated cultures. In-
deed, 3-d treatment of chondrocytes with RA led to a
significant relocation of annexins II, V, and VI from the
cytoplasm to the plasma membrane. Cotreatment with
BAPTA reduced the amount of plasma membrane–bound
annexin II, V, and VI to levels similar as in untreated cul-
tures (Fig. 7). Next, we tested whether RA treatment not
only leads to a relocation of annexins to the plasma mem-
brane, but also to Ca
2  channel formation. Therefore, we
cotreated growth plate chondrocytes with RA and the spe-
cific annexin Ca
2  channel blocker K-201 and measured
[Ca
2 ]i after 1-d treatment. As shown above, RA treatment
led to more than threefold increase in [Ca
2 ]i compared
with the levels in untreated cultures. Interestingly, K-201
significantly reduced this increase in RA-treated cultures.
[Ca
2 ]i was only slightly higher in RA/K-201-treated cul-
tures compared with untreated cultures, indicating that the
majority of the increased [Ca
2 ]i in growth plate chondro-
cytes is due to the influx of Ca
2  through annexin channels
(Fig. 8). Finally, to test whether all three annexins form
Ca
2  channels in the plasma membrane, we treated chon-
drocyte cultures with RA and antibodies specific for annexin
II, V, or VI. The anti–annexin V IgG fraction decreased
RA-mediated increase in [Ca
2 ]i by 75%, the anti–annexin
VI IgG fraction by 65%, and the anti–annexin II IgG frac-
Figure 8. Cytosolic calcium concentration in untreated, RA-, RA/
K-201-, RA/anti–annexin II IgG, RA/anti–annexin V IgG, RA/anti–
annexin VI IgG-treated chondrocytes. [Ca
2 ]i in chondrocytes was 
measured after 1-d treatment with RA, RA/K-201, RA/anti–annexin II 
IgG, RA/anti–annexin V IgG, and RA/anti–annexin VI IgG as described 
in Materials and methods. Data were obtained from four different 
experiments and values are mean   SD. ( , P   0.01 vs. RA-treated 
cultures.)
Figure 9. Quantitative real time PCR analysis of annexin II, V, 
and VI, and type X collagen gene expression in chondrocytes 
treated with RA or RA/BAPTA. Total RNA was isolated from 1- to 6-d 
untreated, RA-, and RA/BAPTA-treated chondrocytes. Annexin II, V, 
and VI, and type X collagen gene expression were detected by 
quantitative real-time PCR using SYBR Green. PCR reactions were 
run in triplicates. Data were obtained from triplicated PCR reactions 
of three different cultures and values are mean   SD ( , P   0.01, 
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tion by 57%, indicating that all three annexins form Ca
2 
channels in the plasma membrane of growth plate chondro-
cytes and mediate Ca
2  influx into these cells (Fig. 8).
Interestingly, annexin-mediated Ca
2  influx into growth
plate chondrocytes led to the up-regulation of their own
gene expression. Real-time PCR analysis revealed a three- to
sevenfold up-regulation of annexin II, V, and VI gene ex-
pression after 3- and 4-d treatment with RA. Chelation of
cytosolic Ca
2  with BAPTA decreased up-regulation of an-
nexin gene expression (Fig. 9, A–C). In this study chondro-
cytes were isolated from the hypertrophic zone of tibia
growth plate cartilage, and thus these cells showed high ex-
pression levels of type X collagen. RA or RA/BAPTA treat-
ment did not further increase these already high type X col-
lagen expression levels (Fig. 9 D). The fact that RA and RA/
BAPTA treatment does not alter the high expression of type
X collagen in growth plate chondrocytes reveals that these
treatments do not change the chondrocytic phenotype.
Discussion
Ca
2  homeostasis controls a diverse range of cellular func-
tions including adhesion, motility, gene expression, prolifer-
ation, and differentiation. Interestingly, many studies have
demonstrated that hypertrophic growth plate chondrocytes
can accumulate large amounts of cytosolic calcium, suggest-
ing that these increases might regulate chondrocyte differen-
tiation and mineralization. Here we provide direct evidence
that RA treatment, which has been shown to induce termi-
nal differentiation and mineralization of growth plate chon-
drocytes (Iwamoto et al., 1993; Kirsch et al., 2000a), leads
to an increase in [Ca
2 ]i. This increase regulates a whole se-
ries of events eventually leading to matrix mineralization of
growth plate chondrocytes: up-regulation of annexin II, V,
and VI gene expression, release of APase- and annexin II, V,
and VI–containing matrix vesicles, and initiation of mineral-
ization by these vesicles. Moreover, the increase in [Ca
2 ]i
during terminal differentiation of growth plate chondrocytes
is to a large degree mediated by annexins II, V, and VI.
These annexins form Ca
2  channels in the plasma mem-
brane of RA-treated chondrocytes, enabling Ca
2  influx into
these cells. Thus, through alteration of Ca
2  homeostasis in
growth plate chondrocytes, annexins II, V, and VI regulate
their own gene expression and subsequent release of an-
nexin-containing, mineralization-competent matrix vesicles.
Our results reveal that under certain physiological condi-
tions, annexins are able to form Ca
2  channels. These find-
ings present a new concept to regulate Ca
2  homeostasis by
annexin Ca
2  channels. Annexins are cytosolic proteins,
which in the presence of Ca
2 , can bind to acidic phospho-
lipids. However, channel formation not only requires mem-
brane binding, but also membrane insertion. Previous stud-
ies have provided evidence that annexins V, VI, and XII can
insert into the membrane and form Ca
2  channels at low
pH in a Ca
2 -independent manner (Isas et al., 2000; Gol-
czak et al., 2001a,b). For example, annexin VI undergoes
major conformational changes under low pH that leads to
an increase of hydrophobicity (Golczak et al., 2001a,b). Fur-
thermore, a biophysical study has demonstrated that the sec-
ondary structure of annexin V is affected by the combined
interactions with Ca
2  and membrane components (Wu et
al., 1999). Interestingly, a recent study has shown that an-
nexin V mediates peroxide-induced Ca
2  influx into B cells
under physiological pH (Kubista et al., 1999). These and
our findings indicate that the cell not only can regulate gene
expression of annexins, but also their channel formation, al-
lowing a precise regulation of the biological consequences of
annexin channel formation. It is not clear which factors reg-
ulate physiological channel formation by annexins. It is pos-
sible that a certain Ca
2  concentration is required for mem-
brane binding and channel formation. Other possibilities are
that intracellular acidification or, as we have shown previ-
ously, the lipid composition of the membrane, may play reg-
ulatory roles in annexin channel formation (Kirsch et al.,
1997a). Furthermore, a previous study has shown that vita-
min D caused an increase in fluidity of the plasma mem-
brane (Swain et al., 1993). Thus, it is possible that RA has a
similar effect on the plasma membrane that could favor an-
nexin channel formation.
Our results and the findings showing that annexin V me-
diated peroxide-induced Ca
2  influx into B cells (Kubista et
al., 1999) establish that annexin Ca
2  channels have impor-
tant physiological functions in altering cell behavior and dif-
ferentiation. In case of growth plate chondrocytes, annexin
channel formation regulates Ca
2  homeostasis in these cells,
and thereby the mineralization process including the release
of mineralization-competent matrix vesicles. These vesicles
contain annexins II, V, and VI as major components (Genge
et al., 1989). We have demonstrated that these annexins also
form Ca
2  channels in matrix vesicles, allowing Ca
2  influx
into these particles and the formation of the first mineral
phase inside the vesicles (Kirsch et al., 2000b). Thus, these
annexins not only regulate Ca
2  homeostasis in growth plate
chondrocytes, but they also play a direct role in the initiation
of mineralization. Interestingly, our data indicate that an-
nexin-mediated Ca
2  influx into growth plate chondrocytes
up-regulates annexin gene expression. Thus, these annexins
regulate their own gene expression, thereby possibly enabling
sufficient amounts of annexins II, V, and VI to be available
for the release of mineralization-competent matrix vesicles.
[Ca
2 ]i in hypertrophic chondrocytes is higher than the
concentration in immature chondrocytes (Iannotti and
Brighton, 1989; Gunter et al., 1990). As indicated by previ-
ous studies, this increase is most likely mediated by other
Ca
2  channels than the annexins (Zimmermann et al.,
1994; Zuscik et al., 1997). Initial increased [Ca
2 ]i might
lead to annexin Ca
2  channel formation and subsequent fur-
ther increase in [Ca
2 ]i. K-201 treatment, which inhibits
Ca
2  channel activities of annexin II, V, and VI (Kirsch et
al., 2000b), did not completely reduce RA-mediated in-
crease in [Ca
2 ]i to levels in untreated cultures. However,
K-201 reduced the increase by  87%, indicating that the
majority of Ca
2  influx into growth plate chondrocytes is
mediated by annexins. There are several reasons why K-201
did not completely inhibit RA-mediated increase in [Ca
2 ]i.
First, we have shown that the concentration of K-201 re-
quired to completely block annexin II–, V–, and VI–medi-
ated Ca
2  influx into artificial liposomes or matrix vesicles is
100  M (Kirsch et al., 2000b). However, 100  M K-201 is
toxic to chondrocytes (unpublished data). Thus, it is possi- Retinoic acid, annexins, and chondrocyte differentiation | Wang and Kirsch 1067
ble that 20  M K-201, which was not toxic to the cells,
might not completely block annexin channels. Another pos-
sibility is that growth plate chondrocytes contain other Ca
2 
channels that might contribute to the Ca
2  influx into RA-
treated chondrocytes. Previous characterizations of Ca
2 
channels in growth plate chondrocytes are controversial.
One study provided evidence that growth plate chondro-
cytes contain N-type Ca
2  channels, whereas another study
suggested that growth plate chondrocytes contain L-type
Ca
2  channels (Zimmermann et al., 1994; Zuscik et al.,
1997). Each antibody specific for annexin II, V, or VI de-
creased RA-mediated increase in [Ca
2 ]i by between 57 and
75%, revealing that all three annexins contribute to Ca
2  in-
flux into growth plate chondrocytes and blocking the chan-
nel activities of one annexin only partially reduces RA-medi-
ated increase in [Ca
2 ]i. Thus, our findings indicate that the
annexins contribute the majority to the alteration of Ca
2 
homeostasis in RA-treated growth plate chondrocytes and
thereby regulate the mineralization process.
Annexin-mediated Ca
2  influx into growth plate chon-
drocytes may be directly involved in the release of mineral-
ization-competent matrix vesicles. Vesiculation or ectocyto-
sis of the plasma membrane has been shown to be dependent
on an influx of Ca
2  into the cytoplasm of many cell types.
Ca
2  ionophores can cause microvesiculation and mem-
brane shedding in a variety of cell types, including chondro-
cytes, fibroblasts, neutrophils, and platelets (Wiedmer et al.,
1990; Iannotti et al., 1994; Bucki et al., 1998). In contrast,
when platelets were suspended in a solution containing
EDTA, microparticle formation was inhibited (Wiedmer et
al., 1990). Furthermore, we and others have provided evi-
dence that matrix vesicles contain Ca
2 -Pi-phospholipid or
nucleational core complex. This core complex is required for
the formation of the first mineral phase inside the vesicles
(Kirsch et al., 1994; Wu et al., 1997). There is some evi-
dence to suggest that this complex might already be assem-
bled at the plasma membrane of the cell before matrix vesi-
cles are released (Wuthier, 1982). Thus, it is possible that
high [Ca
2 ]i is required for the assembly of this complex.
Our study indicates that RA action is required for com-
pletion of the chondrocyte maturation process, and it pro-
vides the first important insight into the underlying mecha-
nisms. Interestingly, a previous study demonstrated that the
perichondral tissue surrounding the cartilage contained
large amounts of retinoids and that implantation of beads
containing RA antagonist near the humeral anlagen severely
affected humerus development (Koyama et al., 1999).
Thus, it is likely that RA plays an important role in regulat-
ing mineralization and terminal differentiation of growth
plate chondrocytes in vivo.
In conclusion, our findings provide evidence that RA
treatment of growth plate chondrocytes leads to Ca
2  chan-
nel formation by annexins II, V, and VI and influx of Ca
2 
into these cells. The annexin-mediated alteration in Ca
2 
homeostasis regulates a whole sequence of events eventually
leading to matrix mineralization, including up-regulation of
annexin II, V, and VI gene expression, relocation of these
annexins to the plasma membrane, and release of APase-
and annexin-containing matrix vesicles that initiate the
mineralization process.
Materials and methods
Chondrocyte culture
Chondrocytes were isolated from the hypertrophic zone of day 19 embry-
onic chick tibia growth plate cartilage as described previously (Kirsch et
al., 1997b). In brief, sliced hypertrophic zone of growth plate cartilage was
digested with 0.25% trypsin and 0.05% collagenase for 5 h at 37 C. Cells
were plated at a density of 3   10
6 into 10-cm tissue culture dishes and
grown in monolayer cultures in DME (GIBCO BRL) containing 5% FCS
(Hyclone), 2 mM L-glutamine (GIBCO BRL), and 50 U/ml penicillin and
streptomycin (complete medium; GIBCO BRL). After cultures reached con-
fluency, chondrocytes were cultured in the presence of 1.5 mM phos-
phate, and in the absence or presence of (a) 35 nM RA (Sigma-Aldrich), (b)
35 nM RA   10  M BAPTA-AM (Molecular Probes, Inc.), (c) 35 nM RA  
5 mM EDTA, (d) 35 nM RA   20  M 1,4-benzothiazepine derivative
K-201 (JTV519) (provided by Drs. Noboro Kareko [Dokkyo University,
Tochigo, Japan] and Toshizo Tanaka [Japan Tobcco Inc., Osaka, Japan]),
or (e) 35 nM RA   20  g/ml IgG fractions specific for annexin II, V, or VI.
[Ca
2 ]i of chondrocytes was measured after 1-d treatment, matrix vesicles
were isolated after 3-d treatment, and the degree of mineralization in these
cultures was determined after 6-d treatment.
Measurement of [Ca
2 ]i
Chondrocytes were trypsinized first, and then 2   10
6 cells were incu-
bated with 4  M of fura-2AM (Molecular Probes, Inc.) at 37 C for 15 min
in complete medium. [Ca
2 ]i was measured as described previously
(Kirsch et al., 1992). Briefly, labeled cells were resuspended in measuring
buffer ([mM] 140 NaCl, 5 KCl, 1 CaCl2, 20 Hepes, 1 NaH2PO4, 5.5 glu-
cose, pH 7.4), transferred to a cuvette (magnetically stirred), and fluores-
cence was measured in a fluorimeter (Photon Technology Instruments) us-
ing the excitation wavelength of 340 nm (Ca
2 -bound form of fura-2AM)
and the emission wavelength of 510 nm. The fluorescence maximum (Fmax)
was determined by addition of 2 pM ionomycin (Calbiochem-Novabio-
chem), and the fluorescence minimum (Fmin) was determined in the pres-
ence of 1 mM EDTA/10 mM Tris. [Ca
2 ]i was calculated according to the
following equation: ([Ca
2 ]i   Kd   [(F   Fmin)/(Fmax   F)] with Kd   224
nM (Grynkiewicz et al., 1985).
Isolation of total RNA and real-time PCR 
Total RNA was isolated from chondrocyte cultures after 1-, 2-, 3-, 4-, 5-,
and 6-d treatments using RNeasy Mini Kit (QIAGEN). 1  g RNA was re-
verse transcribed using Ominiscript RT Kit (QIAGEN). Then a 1:100 dilu-
tion of the resulting cDNA was used as the template to quantitate the rela-
tive content of mRNA by real-time PCR (ABI PRISM 7700 sequence
detection system) using respective primers and SYBR Green. The following
primers for real-time PCR were designed using Primers Express software:
annexin II, forward primer 5 -CATGCCTATCTGCTCTTCGTT-3 , reverse
primer 5 -AGCCACCACACCGTCCATAA-3 ; annexin V, forward primer 5 -
AGAGACATCAGGCCATTTTCAGA-3 , reverse primer 5 -CTGCCATCAG-
GATCTCTATTTGC-3 ; annexin VI, forward primer 5 -GCGGCTGATTG-
TAAGCTTGAT-3 , reverse primer 5 -GTCGGTGGTCCAGCACTTA-3 ; and
type X collagen, forward primer 5 -AGTGCTGTCATTGATCTCATGGA-3 ,
reverse primer 5 -TCAGAGGAATAGAGACCATTGGATT-3 . PCR reactions
were performed with TaqMan PCR master mix kit (Applied Biosystems).
The 18 S RNA was amplified at the same time and used as an internal con-
trol. The cycle threshold values for 18 S RNA and that of the samples were
measured and calculated by computer software. Relative transcript levels
were calculated as x   2
   Ct, in which   Ct    E    C, and  E  
Ctexp   Ct18S;  C   Ctctl   Ct18S.
Isolation of matrix vesicles 
Matrix vesicles were isolated from chondrocyte cultures by enzymatic di-
gestion as described previously (Kirsch et al., 1997b). Briefly, adherent
chondrocyte layers were washed with PBS and incubated with crude col-
lagenase (500 U/ml; type IA; Sigma Chemical Co.) in HBSS at 37 C for 3 h.
Matrix vesicles were harvested by different ultracentrifugation.
Ca
2  uptake by matrix vesicles 
Ca
2  uptake by matrix vesicles was assayed by incubating matrix vesicle
aliquots (100  g of protein) in 400  l of synthetic cartilage lymph solution
at 37 C for 24 h. After incubation, matrix vesicles were pelleted, washed
twice in TNE buffer (TES pH 7.4, NaCl 1.5 mM and EDTA 2  M), resus-
pended in TNE buffer containing 1  M fura-2, transferred to a cuvette, and
fluorescence was measured in fluorimeter using the excitation wavelength
of 340 nm and the emission wavelength of 510 nm. Matrix vesicles were
lysed with 1% Triton X-100 to release intravesicular calcium.1068 The Journal of Cell Biology | Volume 157, Number 6, 2002
Recombinant annexin proteins and antibodies 
Recombinant annexins II, V, and VI were prepared using the pGEX expres-
sion vector (Amersham Pharmacia Biotech) as described previously (Kirsch
et al., 1997a). The preparation of antibodies specific for annexins II, V, and
VI were also described previously (Kirsch et al., 2000c, 2001).
SDS-PAGE and immunoblotting 
Samples were dissolved in 3% SDS sample buffer with DTT, denatured at
100 C for 3 min, and analyzed by electrophoresis in 10 or 12% (wt/vol)
SDS–polyacrylamide gels. Samples were electroblotted onto nitrocellulose
filters after electrophoresis. After blocking with a solution of low-fat milk
protein, blotted proteins were immunostained with primary antibodies fol-
lowed by peroxidase-conjugated secondary antibody, and the signal was
detected by enhanced chemiluminescene (Pierce Chemical Co.).
Measurement of APase activity and protein content 
The measurements of APase activity and protein content were described
previously (Kirsch et al., 1997b). Cells or vesicles were washed in PBS and
suspended in 10 mM Tris-HCl, pH 7.5, 0.1% Triton X-100, and 0.5 mM
MgCl2. Protein content was analyzed by BCA assay (Pierce Chemical Co.).
APase activity was determined using p-nitrophenyl phosphate as a sub-
strate (Tietz et al., 1983).
Alizarin red S staining 
To determine the degree of mineralization in chondrocyte cultures, cul-
tures were stained with alizarin red S. After washing, chondrocyte cultures
were fixed with 70% ethanol for 10 min, and then stained with 0.5% al-
izarin red S in H2O, pH 4.0, for 5 min at room temperature. After staining,
cultures were washed three times with H2O followed by 70% ethanol. To
quantify matrix mineralization, the alizarin red S–stained cultures were in-
cubated with 100 mM cetylpyridinium chloride for 1 h to solubilize and
release calcium-bound alizarin red into solution (Johnson et al., 2001).
The absorbance of the released alizarin red S was measured at 570 nm us-
ing a spectrophotometer. Data are expressed as units of alizarin red S re-
leased per milligram of protein in each culture.
Statistical analysis 
Numerical data are presented as mean   SD (n   4) and statistical signifi-
cance between groups was identified using the two-tailed t test (P values
are reported in the figure legends).
This work was supported by grants from the National Institutes of Health
(National Institute of Arthritis and Musculoskeletal and Skin Diseases, AR
43732 and AR 46245 to T. Kirsch).
Submitted: 4 March 2002
Revised: 17 April 2002
Accepted: 19 April 2002
References
Anderson, H.C. 1995. Molecular biology of matrix vesicles. Clin. Orthop. 314:
266–280.
Benz, J., A. Bergner, A. Hofmann, P. Demange, P. Gottig, S. Liemann, R. Huber,
and D. Voges. 1996. The structure of recombinant human annexin VI in
crystals and membrane-bound. J. Mol. Biol. 260:638–643.
Berendes, R., D. Voges, P. Demange, R. Huber, and A. Burger. 1993. Structure-
function analysis of the ion channel selectivity filter in human annexin V.
Science. 262:427–430.
Bonucci, E., G. Silvestrini, and P. Bianco. 1992. Extracellular alkaline phosphatase
activity in mineralizing matrices of cartilage and bone: ultrastructural local-
ization using a cerium-based method. Histochemistry. 97:323–327.
Bucki, R., C. Bachelot-Loza, A. Zachowski, F. Giraud, and J.C. Sulpice. 1998.
Calcium induces phospholipid redistribution and microvesicle release in hu-
man erythrocyte membranes by independent pathways. Biochemistry. 37:
15383–15391.
Buckwalter, J.A., D. Mower, and J. Schaeffer. 1987. Differences in matrix vesicle
concentration among growth plate zones. J. Orthop. Res. 5:157–163.
Burger, A., R. Berendes, S. Liemann, J. Benz, A. Hofmann, P. Gottig, R. Huber,
V. Gerke, C. Thiel, J. Romisch, and K. Weber. 1996. The crystal structure
and ion channel activity of human annexin II, a peripheral membrane pro-
tein. J. Mol. Biol. 257:839–847.
Chen, J.M., A. Sheldon, and M.R. Pincus. 1993. Structure-function correlations of
calcium binding and calcium channel activities based on 3-dimensional
models of human annexins I, II, III, V and VII. J. Biomol. Struct. Dyn. 10:
1067–1089.
Crompton, M.R., S.E. Moss, and M.J. Crumpton. 1988. Diversity in the lipocor-
tin/calpactin family. Cell. 55:1–3.
Doyle, D.V. 1982. Tissue calcification and inflammation in osteoarthritis. J.
Pathol. 136:199–216.
Geisow, M.J., J.H. Walker, C. Boustead, and W. Taylor. 1988. Annexins: a new
family of Ca
2  regulated phospholipid-binding proteins. In Molecular
Mechanisms in Secretion. N.A. Thorn, M. Traiman, and O.H. Peterson,
editors. Munksgaard, Copenhagen. 598–608.
Genge, B.R., L.N.Y. Wu, and R.E. Wuthier. 1989. Identification of phospholipid-
dependent calcium-binding proteins as constituents of matrix vesicles. J.
Biol. Chem. 264:10917–10921.
Giachelli, C.M. 1999. Ectopic calcification: gathering hard facts about soft tissue
mineralization. Am. J. Pathol. 154:671–675.
Golczak, M., A. Kirilenko, J. Bandorowicz-Pikula, and S. Pikula. 2001a. Confor-
mational states of annexin VI in solution induced by acidic pH. FEBS Lett.
496:49–54.
Golczak, M., A. Kirilenko, J. Bandorowicz-Pikula, and S. Pikula. 2001b. N- and
C-terminal halves of human annexin VI differ in ability to form low pH-
induced ion channels. Biochem. Biophys. Res. Commun. 284:785–791.
Grynkiewicz, G., M. Poenie, and R.Y. Tsien. 1985. A new generation of Ca
2  indi-
cators with greatly improved fluorescence properties. J. Biol. Chem. 260:
3440–3450.
Gunter, T.E., M.J. Zuscik, J.E. Puzas, K.K. Gunter, and R.N. Rosier. 1990. Cyto-
solic free calcium concentrations in avian growth plate chondrocytes. Cell
Calcium. 11:445–457.
Iannotti, J.P., and C.T. Brighton. 1989. Cytosolic ionized calcium concentration
in isolated chondrocytes from each zone of the growth plate. J. Orthop. Res.
7:511–518.
Iannotti, J.P., S. Naidu, Y. Noguchi, R.M. Hunt, and C.T. Brighton. 1994.
Growth-plate matrix vesicle biogenesis. The role of intracellular calcium.
Clin. Orthop. 306:222–229.
Isas, J.M., J.-P. Cartailler, Y. Sokolov, D.R. Patel, R. Langen, H. Luecke, J.E. Hall,
and H.T. Haigler. 2000. Annexins V and XII insert into bilayers at mildly
acidic pH and form ion channels. Biochemistry. 39:3015–3022.
Iwamoto, M., I.M. Shapiro, K. Yagami, A.L. Boskey, P.S. Leboy, S.L. Adams, and
M. Pacifici. 1993. Retinoic acid induces rapid mineralization and expression
of mineralization-related genes in chondrocytes. Exp. Cell Res. 207:413–420.
Johnson, K., S. Hashimoto, M. Lotz, K. Pritzker, J. Goding, and R. Terkeltaub.
2001. Up-regulated expression of the phosphodiesterase nucleotide pyro-
phosphatase family member PC-1 is a marker and pathogenic factor for knee
meniscal cartilage matrix calcification. Arthritis Rheum. 44:1071–1081.
Kaneko, N. 1994. New 1,4-benzothiazepine derivative, K201, demonstrates car-
dioprotective effects against sudden cardiac cell death and intracellular
blocking action. Drug Dev. Res. 33:429–438.
Kaneko, N., H. Ago, R. Matsuda, E. Inagaki, and M. Miyano. 1997. Crystal struc-
ture of annexin v with its ligand K-201 as a calcium channel activity inhibi-
tor. J. Mol. Biol. 274:16–20.
Kirsch, T., and K. von der Mark. 1992. Remodelling of collagen types I, II and X
and calcification of human fetal cartilage. Bone Miner. 18:107–117.
Kirsch, T., B. Swoboda, and K. von der Mark. 1992. Ascorbate independent differ-
entiation of human chondrocytes in vitro: simultaneous expression of types I
and X collagen and matrix mineralization. Differentiation. 52:89–100.
Kirsch, T., Y. Ishikawa, F. Mwale, and R.E. Wuthier. 1994. Roles of the nucle-
ational core complex and collagens (types II and X) in calcification of growth
plate cartilage matrix vesicles. J. Biol. Chem. 269:20103–20109.
Kirsch, T., H.-D. Nah, D.R. Demuth, G. Harrison, E.E. Golub, S.L. Adams, and
M. Pacifici. 1997a. Annexin V-mediated calcium flux across membranes is
dependent on the lipid composition. Implications for cartilage mineraliza-
tion. Biochemistry. 36:3359–3367.
Kirsch, T., H.D. Nah, I.M. Shapiro, and M. Pacifici. 1997b. Regulated produc-
tion of mineralization-competent matrix vesicles in hypertrophic chondro-
cytes. J. Cell Biol. 137:1149–1160.
Kirsch, T., G. Harrison, and E.E. Golub. 2000a. Regulatory roles of zinc in matrix
vesicle-mediated mineralization of growth plate cartilage. J. Bone Miner. Res.
15:261–270.
Kirsch, T., G. Harrison, E.E. Golub, and H.-D. Nah. 2000b. The roles of annex-
ins and types II and X collagen in matrix vesicle-mediated mineralization of
growth plate cartilage. J. Biol. Chem. 275:35577–35583.
Kirsch, T., B. Swoboda, and H.-D. Nah. 2000c. Activation of annexin II and V ex- Retinoic acid, annexins, and chondrocyte differentiation | Wang and Kirsch 1069
pression, terminal differentiation, mineralization and apoptosis in human
osteoarthritic cartilage. Osteoarthritis Cartilage. 8:294–302.
Kirsch, T., B. Swoboda, and H.-D. Nah. 2001. Expression of early and late differ-
entiation markers (proliferating cell nuclear antigen, syndecan-3, annexin
VI, and alkaline phosphatase) by human osteoarthritic chondrocytes. Am. J.
Pathol. 159:1777–1783.
Koyama, E., E.B. Golden, T. Kirsch, S.L. Adams, R.A.S. Chandraratna, J.-J.
Michaille, and M. Pacifici. 1999. Retinoid signaling is required for chondro-
cyte maturation and endochondral bone formation during limb skeletogene-
sis. Dev. Biol. 208:375–391.
Kubista, H., T.E. Hawkins, D.R. Patel, H.T. Haigler, and S.E. Moss. 1999. Annexin V
mediates a peroxidase-induced Ca
2  influx in B cells. Curr. Biol. 9:1403–1406.
Matsuda, R., N. Kaneko, and Y. Horikawa. 1997. Presence and comparison of
Ca
2  transport activity of annexins I, II, V, and VI in large unilamellar vesi-
cles. Biochem. Biophys. Res. Commun. 237:499–503.
Mitchell, P.G., J.A. Struve, G.M. McCarthy, and H.S. Cheung. 1992. Basic calcium
phosphate crystals stimulate cell proliferation and collagenase message accumu-
lation in cultured adult articular chondrocytes. Arthritis Rheum. 35:343–350.
Montessuit, C., J. Caverzasio, and J.P. Bonjour. 1991. Characterization of a Pi
transport system in cartilage matrix vesicles. Potential role in the clarification
process. J. Biol Chem. 266:17791–17797.
Montessuit, C., J.P. Bonjour, and J. Caverzasio. 1995. Expression and regulation
of Na-dependent P(i) transport in matrix vesicles produced by osteoblast-
like cells. J. Bone Miner. Res. 10:625–631.
Reinholt, F.P., B. Engfeldt, A. Hjerpe, and K. Jansson. 1982. Stereological studies
on the epiphyseal growth plate with special reference to the distribution of
matrix vesicles. J. Ultrastruct. Res. 80:270–279.
Swain, L.D., Z. Schwartz, K. Caulfield, B.P. Brooks, and B.D. Boyan. 1993. Non-
genomic regulation of chondrocyte membrane fluidity by 1,25-(OH)2d3
and 24,25-(OH)2d3 is dependent on cell maturation. Bone. 14:609–617.
Tietz, N.W., C.A. Burtis, P. Duncan, K. Ervin, C.J. Petitclerd, A.D. Rinker, D.
Shney, and E.R. Zygowicz. 1983. A reference method for measurement of
alkaline phosphatase activity in human serum. Clin. Chem. 29:751–761.
Wiedmer, T., S.J. Shattil, M. Cunningham, and P.J. Sims. 1990. Role of calcium
and calpain in complement-induced vesiculation of the platelet plasma
membrane and its exposure of the platelet factor Va receptor. Biochemistry.
29:623–632.
Wu, F., C.R. Flach, B.A. Seaton, T.R. Mealy, and R. Mendelsohn. 1999. Stability
of annexin V in ternary complexes with Ca
2  and anionic phospholipids: IR
studies of monolayer and bulk phases. Biochemistry. 38:792–799.
Wu, L.N.Y., B.R. Genge, D.G. Dunkelberger, R.Z. Legeros, B. Concannon, and
R.E. Wuthier. 1997. Physicochemical characterization of the nucleational
core of matrix vesicles. J. Biol. Chem. 272:4404–4411.
Wuthier, R.E. 1982. A review of the primary mechanism of endochondral calcifi-
cation with special emphasis on the role of cells, mitochondria and matrix
vesicles. Clin. Orthop. 169:219–242.
Zimmermann, B., K. Lange, P. Mertens, and J. Bernimoulin. 1994. Inhibition of
chondrogenesis and endochondral mineralization in-vitro by different cal-
cium-channel blockers. Eur. J. Cell Biol. 63:114–121.
Zuscik, M.J., T.E. Gunter, J.E. Puzas, and R.N. Rosier. 1997. Characterization of
voltage-sensitive calcium channels in growth plate chondrocytes. Biochem.
Biophys. Res. Commun. 234:432–438.